These findings suggest that PAR-1-dependent stimulation of tumor growth and metastasis is regulated by invasive, adhesive and proangiogenic factors and that PAR-1 could be a potential therapeutic target for metastatic melanoma patients. The gene discussed is F2R; the disease is metastatic melanoma.